US Renal Care raises $328 million for innovation, value-based care
Click Here to Manage Email Alerts
Key takeaways:
- U.S. Renal Care plans to finance innovation-focused programs with $328 million of new capital.
- Some of the cash will also be used to enhance Kidneylink.
U.S. Renal Care announced it has raised $328 million in new capital, which it plans to use for growth and expansion.
According to a press release, U.S. Renal Care (USRC) said the cash influx will finance innovation-focused programs, as well as continued kidney care and professional development. Some of the funds will also enhance Kidneylink, the value-based care business of the company.
“USRC has invested and will continue to invest substantially in our physician partnerships, clinical capabilities, growth, and infrastructure,” Mark Caputo, MBA, CEO and chairman of USRC, said in the release. “We are already a leader in clinical quality, as evidenced by the recent CMS publication of [Quality Incentive Program] QIP results, achieving some of the best outcomes in the industry, and this new capital will further enhance our investment and growth capacity.”
USRC operates more than 400 in-center and home dialysis programs in 33 states. According to the release, 22% of all practicing nephrologists in the United States treat patients in USRC clinics, and about 27,000 patients with kidney disease visit its clinics nationwide.
Read more about
Click Here to Manage Email Alerts